Clinical Updates

Abbott Laboratories Inc’s weight-loss drug Meridia should be banned immediately because of heart-related risks, a consumer group said on Thursday… »   

An antibiotic that binds to a well-established target in a novel and unexpected way could be the inspiration for designing… »   

Commonly prescribed beta 2 adrenergic agonist drugs for the treatment of asthma in pregnant women as well as pre-term labor… »   

Overall, antipsychotic medications are reasonably effective, and fairly well tolerated treatments for mood and psychotic disorders. However, treatment with… »   

Countries should phase out the use of Stavudine, the most widespread antiretroviral, because of “long-term, irreversible” side-effects in HIV patients… »   

The copper sequestering drug tetrathiomolybdate (TM) has been shown in studies to be effective in the treatment of Wilson disease,… »   

MRSA (methicillin-resistant Staphylococcus Aureus) and other drug-resistant bacteria could face annihilation as low-temperature plasma prototype devices have been developed to… »   

Egypt’s health ministry will give licences to five companies to produce up to 5 million doses of generic H1N1 flu… »   

Preventing disease is the goal of every health care provider and fortunately every year, new vaccines are being added to… »   

Heart risks from taking Merck & Co Inc’s painkiller Vioxx could have been detected more than three years before the… »   

There is no scientific proof that people suffering from depression can benefit from taking reboxetine. However, clinical trials do provide… »   

A Philadelphia jury on Monday ordered Pfizer Inc to pay $28 million in punitive damages to a breast cancer survivor… »   

Older adults who take several types of psychotropic medications—such as antidepressants or sedatives—appear more likely to experience falls, according to… »   

Clinical trial data indicated an association between the anti-inflammatory medication rofecoxib and cardiovascular risk as early as December 2000, before… »   

Vioxx Trial Data Shows Early Cardiovascular Risk, Provides Lessons for Post-Market Pharmaceutical Safety

Evidence of cardiovascular risks associated… »